Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Vitamins and Hormones|January 26, 2019
Mineralocorticoid Receptor AntagonistsAnneli Nordqvist, Kenneth L Granberg
Journal of Computer-Aided Molecular Design|November 18, 2015
Predicting the relative binding affinity of mineralocorticoid receptor antagonists by density functional methodsKatarina Roos, Anders Hogner, Derek Ogg, et al.
The ISME Journal|November 29, 2007
Links between bacterial production, amino-acid utilization and community composition in productive lakesStefan Bertilsson, Alexander Eiler, Anneli Nordqvist, et al.
Plos One|April 6, 2023
The allosterically modulated FFAR2 is transactivated by signals generated by other neutrophil GPCRsSimon Lind, Kenneth L Granberg, Huamei Forsman, et al.
Chemmedchem|April 30, 2026
Mineralocorticoid Receptor Antagonists With an Acylurea as a Key Polar Interaction MotifAnneli Nordqvist, Bo Lindmark, Kenneth L Granberg, et al.
Chemmedchem|November 30, 2016
Structure-Based Drug Design of Mineralocorticoid Receptor Antagonists to Explore Oxosteroid Receptor SelectivityAnneli Nordqvist, Gavin O'Mahony, Maria Fridén-Saxin, et al.
ACS Pharmacology & Translational Science|March 29, 2020
Structural Characterization of Agonist Binding to Protease-Activated Receptor 2 through Mutagenesis and Computational ModelingAmanda J Kennedy, Flavio Ballante, Johan R Johansson, et al.
The Journal of Organic Chemistry|September 23, 2011
Synthesis of functionalized cinnamaldehyde derivatives by an oxidative Heck reaction and their use as starting materials for preparation of Mycobacterium tuberculosis 1-deoxy-D-xylulose-5-phosphate reductoisomerase inhibitorsAnneli Nordqvist, Christofer Björkelid, Mounir Andaloussi, et al.
Biochemical Pharmacology|September 9, 2021
Multiple ligand recognition sites in free fatty acid receptor 2 (FFA2R) direct distinct neutrophil activation patternsSimon Lind, André Holdfeldt, Jonas Mårtensson, et al.
Bioorganic & Medicinal Chemistry Letters|June 30, 2009
Functionalized 3-amino-imidazo[1,2-a]pyridines: a novel class of drug-like Mycobacterium tuberculosis glutamine synthetase inhibitorsLuke R Odell, Mikael T Nilsson, Johan Gising, et al.
Pageof 3